Shancyte 1gm Injection
Marketer
Shantha Biotech
Salt Composition
Gemcitabine (1gm)
Overview Shancyte 1gm Injection
Cytosol Injection (1g) is indicated for treating several cancers, including non-small cell lung, breast, pancreatic, bladder, and ovarian cancers. Administration is strictly via intravenous injection by a healthcare professional. Dosage and frequency are determined by your physician, tailored to your specific condition and potentially adjusted over time. Always adhere precisely to your doctor's instructions; incorrect usage or overdose can lead to severe adverse effects. Therapeutic benefits may not be apparent immediately; several weeks or months may pass. Do not discontinue treatment without consulting your doctor. Common side effects include nausea, vomiting, anorexia, alopecia, and thrombocytopenia. This medication can lower blood cell counts (red and white), increasing infection risk. Regular blood tests to monitor blood cell counts, as well as heart, liver, and uric acid levels, are essential. Inform your doctor of pre-existing heart, liver, or kidney conditions, or any concurrent use of anti-infective medications before commencing treatment. Potential drug interactions exist; disclose all medications you are currently taking. This injection is contraindicated during pregnancy and lactation. Reliable contraception for both partners is crucial throughout the treatment period to prevent conception.
Primary Ingredients of Shancyte 1gm Injection
The provided text is "undefined," so no rephrasing is possible.
Uses of Shancyte 1gm Injection
Lung cancer (non-small cell type), breast cancer, pancreatic cancer, bladder cancer, and ovarian cancer.
Major Benefits of Shancyte 1gm Injection:
This medication will be administered by your healthcare provider. Self-medication is strictly prohibited.
Common Side effects of Shancyte 1gm Injection:
- Nausea
- Vomiting
- Loss of appetite
- Hair loss
- Low blood platelets
- Allergic reaction
- Breathlessness
- Decreased white blood cell count
- Increased liver enzymes
- Anemia (low number of red blood cells)
- Flu-like symptoms
- Blood in urine
- Skin rash
- Protein in urine
How to use Shancyte 1gm Injection:
This medication will be administered by your healthcare provider. Self-medication is strongly discouraged.
How Shancyte 1gm Injection works:
Shancyte 1gm Injection inhibits cancer cell proliferation by disrupting DNA and RNA synthesis through the replacement of essential cellular components. This action effectively blocks tumor growth and expansion.
SAFETY ADVICE
AlcoholUNSAFE
Concurrent use of Shancyte 1gm Injection and alcohol may lead to significant somnolence.
PregnancyCONSULT YOUR DOCTOR
Administering Shancyte 1gm Injection during pregnancy poses a confirmed risk to the fetus. Therefore, its use is contraindicated. In exceptional, life-threatening circumstances, a physician might prescribe it if the potential benefits outweigh the known dangers. Physician consultation is mandatory.
Breast feedingUNSAFE
Administration of Shancyte 1gm Injection is contraindicated while breastfeeding due to potential infant toxicity. Studies indicate a risk of harm to the nursing infant.
DrivingUNSAFE
Administration of Shancyte 1gm Injection can induce drowsiness, blurred vision, and dizziness, potentially impairing alertness. Driving should be avoided if these effects manifest.
KidneyCONSULT YOUR DOCTOR
Data regarding Shancyte 1gm Injection's use in individuals with renal impairment is scarce. Physician consultation is necessary. Pre-treatment assessment of kidney function is recommended, along with ongoing monitoring post-treatment.
LiverCONSULT YOUR DOCTOR
Data regarding the administration of Shancyte 1gm Injection to individuals with hepatic impairment is scarce. Physician consultation is advised.
What if you forget to take Shancyte 1gm Injection :
NA
Facts to Know About Shancyte 1gm Injection
| Label | Value |
|---|---|
| Chemical Category | Cytosine Analog |
| Developing Habits | No. |
| Type of Therapy | Cancer Treatments |
| Behavioral Class | Metabolic antagonists |
3,018 People bought this recently